01 2TEVA BRANDED PHARM
02 14TEVA PHARM
01 1610124131
01 16Blank
01 16Y
01 162031-05-18
Patent Expiration Date : 2031-05-18
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205636
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208799
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
Patent Expiration Date : 2031-05-18
US Patent Number : 10124131
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208798
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-05-18
